Company: ICUI
Filing Date: 2025-05-08
Form Type: 10-Q
Source: 0000883984-25-000016
Chunk: 54

Company: ICU MEDICAL INC/DE
Filing Date: 2025-05-08
Form: 10-Q
Item: Item 1
Chunk 54
---
 observable market inputs such as known notional value amounts and USD interest rate curves.Our assets and liabilities measured at fair value on a recurring basis consisted of the following Level 1, 2 and 3 inputs as defined above (in thousands): Fair value measurements as of March 31, 2025 Total carryingvalueQuoted pricesin activemarkets foridenticalassets (level 1)Significantotherobservableinputs (level 2)Significantunobservableinputs (level 3)Assets:Foreign exchange contracts:Prepaid expenses and other current assets$3,560 $— $3,560 $— Interest rate contracts:Prepaid expenses and other current assets8,403 — 8,403 — Other assets512 — 512 — Total Assets$12,475 $— $12,475 $— Liabilities:Foreign exchange contracts:Accrued liabilities4,335 — 4,335 — Total Liabilities$4,335 $— $4,335 $— 

23

ICU MEDICAL, INC. AND SUBSIDIARIESNOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS(Continued)

 Fair value measurements as of December 31, 2024 Total carryingvalueQuoted pricesin activemarkets foridenticalassets (level 1)Significantotherobservableinputs (level 2)Significantunobservableinputs (level 3)Assets:Foreign exchange forwards:Prepaid expenses and other current assets6,716 — 6,716 — Interest rate contracts:Prepaid expenses and other current assets11,038 — 11,038 — Other assets5,724 — 5,724 — Total Assets$23,478 $— $23,478 $— Liabilities:Foreign exchange contracts:Accrued liabilities7,391 — 7,391— Total Liabilities$7,391 $— $7,391 $— 

Note 11:  Investment Securities

Investments in Non-Marketable Equity SecuritiesWe own approximately 20% non-marketable equity interest in a nonpublic company and entered into a three-year distribution agreement where we have the exclusive rights to market, sell and distribute the company's products in exchange for a